Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Erbitux
Erbitux
ImClone, Bristol-Myers withdraw FDA application for Erbitux use in a type of lung cancer
Yahoo/AP
Sat, 01/24/09 - 10:28 am
ImClone
Bristol-Myers Squibb
lung cancer
Erbitux
Merck Serono: Study Published in JCO Shows Erbitux Enhances Efficacy in mCRC Patients with KRAS Wild-Type Tumors in 1st-Line Setting
PharmaLive
Mon, 01/5/09 - 09:24 am
Merck Serono
Erbitux
Pages
« first
‹ previous
1
2
3